1-3 of 3
Lucien Noens, MD, PhD
Close
Sort by
Journal Articles

HOVON 104; Results of First 25 Patients from a Multicenter, Multinational, Prospective Phase II Study of Bortezomib Based Induction Treatment Followed By Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Al Amyloidosis

Monique Minnema, Kazem Nasserinejad, MA, Bouke Hazenberg, MD PhD, Ute Hegenbart, Lucien Noens, MD PhD, Paula F. Ypma, MD, Sonja Zweegman, MD PhD, Lidwine Winnifred Tick, MD PhD, Annemiek Broijl, MD PhD, Harry R. Koene, MD PhD, Gerard M.J. Bos, MD PhD, Pieter Sonneveld, MD PhD, Stefan O. Schoenland, MD
Journal: Blood
Blood (2016) 128 (22): 4628.
https://doi.org/10.1182/blood.V128.22.4628.4628
Published: 2016
Journal Articles

Early Post-Transplant Epigenetic Therapy By Panobinostat and Decitabine Followed By Donor Lymphocyte Infusion (DLI): Interim Results of the HOVON-116 Phase I/II Feasibility Study in Poor-Risk AML Recipients of Allogeneic Stem Cell Transplantation (alloHSCT)

Jan J. Cornelissen, MD PhD, Yvette van Norden, MD PhD MSc., Michel van Gelder, MD PhD, Dimitri A. Breems, MD PhD, Johan Maertens, MD PhD, Mojca Jongen-Lavrencic, MD PhD, Annoek Broers, MD PhD, Sacha S. Zeerleder, MD PhD, Lucien Noens, MD PhD, Gert Ossenkoppele, MD PhD, Ellen Meijer, MD PhD
Journal: Blood
Blood (2016) 128 (22): 832.
https://doi.org/10.1182/blood.V128.22.832.832
Published: 2016
Journal Articles

QT Interval Effects and M-Protein Response in a Phase 1 Study of Siltuximab (Anti-IL-6 Monoclonal Antibody) in Patients with Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma.

Sheeba K. Thomas, MD, Alexander Suvorov, MD, Lucien Noens, MD, PhD, Oleg Rukavitsin, MD, Joseph Fay, MD, Ka Lung Wu, MD, PhD, Todd M Zimmerman, MD, Helgi van de Velde, MD, PhD, Rajesh Bandekar, PhD, Thomas A Puchalski, PharmD, Ming Qi, MD, PhD, Clarissa Uhlar, PhD, Olga S Samoilova, MD
Journal: Blood
Blood (2012) 120 (21): 2972.
https://doi.org/10.1182/blood.V120.21.2972.2972
Published: 2012